For detailed information about our third quarter 2024 performance, as well as outlook, please read our Q3 2024 earnings press release and the management commentary we've posted to the Investor ...
SAN FRANCISCO — SAN FRANCISCO — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the San Francisco-based company said it had a loss ...
"This quarter we have made progress against our key objectives and have seen meaningful progress on our Gen 2 R1 cost structure due to the new technologies incorporated into the vehicle and ...
The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 92 cents per share. The cloud-based phone system provider for small businesses posted revenue of $608.8 ...